Results 71 to 80 of about 234,365 (193)
Abstract The clinical landscape of early stage non–small cell lung cancer is at transformative crossroads. Driven by the widespread adoption of low‐dose computed tomography screening, the frequent detection of ground‐glass opacities, and a rising incidence among never‐smokers, the diagnostic center of gravity has shifted toward earlier, potentially ...
Chaoqi Zhang +23 more
wiley +1 more source
ABSTRACT Background Surgical resection is the primary curative option for elderly patients with non‐small cell lung cancer (NSCLC), but its survival benefit remains debated due to comorbidities and competing risks. This study evaluated the dynamic impact of surgery on long‐term survival and developed machine learning models for prognostic prediction ...
Bo Zhou +3 more
wiley +1 more source
Sublobar Resection: Are the Answers Different or Is It the Questions? [PDF]
The review by Blasberg et al.1 re-examines the data regarding the role of sublobar resection for non-small cell lung cancer (NSCLC), a question that was “settled” 15 years ago by the Lung Cancer Study Group.2,3 Indeed, they are not alone, as a randomized study re-examining this question is underway by the Cancer and Leukemia Group B oncology group ...
openaire +1 more source
ABSTRACT Background The optimal therapeutic approach for early‐stage NSCLC (I–II, and, in some specific cases, IIIa) is lung resective surgery with mediastinal lymphadenectomy. However, it should be remarked that lung resection surgery further negatively affects respiratory muscle function and health‐related quality of life (HRQoL).
Giulia M. Stella +10 more
wiley +1 more source
In this propensity score‐matched study of clinical stage I non‐small cell lung cancer, lobe‐specific lymph node dissection achieved comparable overall and relapse‐free survival to systematic lymph node dissection while reducing operative invasiveness and postoperative supraventricular tachyarrhythmia.
Hirotsugu Notsuda +11 more
wiley +1 more source
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study
ObjectiveAt present, even when early-stage, small-sized non–small cell lung cancers are being increasingly detected, lesser resection has not become the treatment of choice.
Kodama, Ken +5 more
core +1 more source
In patients with multiple ipsilateral ground‐glass opacities, resection of ≥ 2 lesions was associated with lower 1‐year retention of FVC, FEV1, and DLCOc‐SB than resection of a single lesion. Simultaneous resection of additional lesions may involve a functional trade‐off.
Jia Han +3 more
wiley +1 more source
Recurrence occurs in 30%–55% of patients following curative‐intent treatment for early‐stage NSCLC. This systematic review and meta‐analysis evaluated molecular prognostic models for predicting recurrence, identifying five eligible models from 2447 records.
Aaron Ling +4 more
wiley +1 more source
O105: Evaluating Surgical Approaches in Non-Small Cell Lung Cancer: Lobectomy vs Sublobar Resection
Background Lung Cancer remains the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for 85% of cases. Lobectomy has long been regarded as the gold-standard treatment for early-stage NSCLC. A shifting paradigm
Asadi, Nizar +4 more
core +1 more source
Jiaqi Zhang ,* Wenliang Bai ,* Chao Guo, Lei Liu, Guige Wang, Cheng Huang, Yeye Chen, Ye Zhang, Shanqing Li Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ...
Zhang J +8 more
doaj

